nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vinorelbine—lung cancer	0.457	0.556	CrCrCtD
Rescinnamine—Voacamine—Vinblastine—lung cancer	0.365	0.444	CrCrCtD
Rescinnamine—ACE—pulmonary artery—lung cancer	0.0125	0.391	CbGeAlD
Rescinnamine—ACE—umbilical vein—lung cancer	0.00825	0.258	CbGeAlD
Rescinnamine—ACE—respiratory system—lung cancer	0.0021	0.0658	CbGeAlD
Rescinnamine—ACE—epithelium—lung cancer	0.00175	0.055	CbGeAlD
Rescinnamine—SLC18A2—lung—lung cancer	0.00163	0.0512	CbGeAlD
Rescinnamine—ACE—cardiac atrium—lung cancer	0.00146	0.0457	CbGeAlD
Rescinnamine—ACE—bone marrow—lung cancer	0.00123	0.0386	CbGeAlD
Rescinnamine—SLC18A2—lymph node—lung cancer	0.00112	0.035	CbGeAlD
Rescinnamine—ACE—lung—lung cancer	0.00111	0.0349	CbGeAlD
Rescinnamine—Voacamine—ABCB1—lung cancer	0.000774	0.647	CrCbGaD
Rescinnamine—ACE—lymph node—lung cancer	0.000763	0.0239	CbGeAlD
Rescinnamine—Reserpine—ABCB1—lung cancer	0.000421	0.352	CrCbGaD
Rescinnamine—Acute coronary syndrome—Etoposide—lung cancer	0.000297	0.00209	CcSEcCtD
Rescinnamine—Hypertension—Vinorelbine—lung cancer	0.000296	0.00208	CcSEcCtD
Rescinnamine—Myocardial infarction—Etoposide—lung cancer	0.000295	0.00208	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Erlotinib—lung cancer	0.000295	0.00208	CcSEcCtD
Rescinnamine—Paraesthesia—Topotecan—lung cancer	0.000294	0.00207	CcSEcCtD
Rescinnamine—Insomnia—Erlotinib—lung cancer	0.000293	0.00206	CcSEcCtD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—lung cancer	0.000293	0.109	CbGpPWpGaD
Rescinnamine—Myalgia—Vinorelbine—lung cancer	0.000292	0.00206	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Paclitaxel—lung cancer	0.000291	0.00205	CcSEcCtD
Rescinnamine—Myocardial infarction—Paclitaxel—lung cancer	0.00029	0.00204	CcSEcCtD
Rescinnamine—Discomfort—Vinorelbine—lung cancer	0.000289	0.00203	CcSEcCtD
Rescinnamine—Constipation—Vinblastine—lung cancer	0.000288	0.00203	CcSEcCtD
Rescinnamine—Pain—Vinblastine—lung cancer	0.000288	0.00203	CcSEcCtD
Rescinnamine—Conjunctivitis—Paclitaxel—lung cancer	0.000287	0.00202	CcSEcCtD
Rescinnamine—Urinary tract infection—Paclitaxel—lung cancer	0.000287	0.00202	CcSEcCtD
Rescinnamine—Constipation—Topotecan—lung cancer	0.00028	0.00197	CcSEcCtD
Rescinnamine—Pain—Topotecan—lung cancer	0.00028	0.00197	CcSEcCtD
Rescinnamine—Vaginal inflammation—Doxorubicin—lung cancer	0.000279	0.00197	CcSEcCtD
Rescinnamine—Rash—Teniposide—lung cancer	0.000279	0.00196	CcSEcCtD
Rescinnamine—Dermatitis—Teniposide—lung cancer	0.000278	0.00196	CcSEcCtD
Rescinnamine—Infection—Vinorelbine—lung cancer	0.000278	0.00196	CcSEcCtD
Rescinnamine—Sinusitis—Paclitaxel—lung cancer	0.000277	0.00195	CcSEcCtD
Rescinnamine—Pain—Erlotinib—lung cancer	0.000277	0.00195	CcSEcCtD
Rescinnamine—Constipation—Erlotinib—lung cancer	0.000277	0.00195	CcSEcCtD
Rescinnamine—Headache—Teniposide—lung cancer	0.000277	0.00195	CcSEcCtD
Rescinnamine—Dermatitis contact—Doxorubicin—lung cancer	0.000276	0.00194	CcSEcCtD
Rescinnamine—Erythema—Gemcitabine—lung cancer	0.000276	0.00194	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vinblastine—lung cancer	0.000276	0.00194	CcSEcCtD
Rescinnamine—Back pain—Irinotecan—lung cancer	0.000274	0.00193	CcSEcCtD
Rescinnamine—Angina pectoris—Docetaxel—lung cancer	0.000274	0.00192	CcSEcCtD
Rescinnamine—Hypoaesthesia—Etoposide—lung cancer	0.000269	0.00189	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Topotecan—lung cancer	0.000268	0.00188	CcSEcCtD
Rescinnamine—Back pain—Gemcitabine—lung cancer	0.000267	0.00188	CcSEcCtD
Rescinnamine—Abdominal pain—Vinblastine—lung cancer	0.000266	0.00187	CcSEcCtD
Rescinnamine—Rhinitis—Paclitaxel—lung cancer	0.000266	0.00187	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Erlotinib—lung cancer	0.000265	0.00186	CcSEcCtD
Rescinnamine—Hypoaesthesia—Paclitaxel—lung cancer	0.000264	0.00186	CcSEcCtD
Rescinnamine—Vaginal infection—Doxorubicin—lung cancer	0.000264	0.00186	CcSEcCtD
Rescinnamine—Pharyngitis—Paclitaxel—lung cancer	0.000263	0.00185	CcSEcCtD
Rescinnamine—Nausea—Teniposide—lung cancer	0.000262	0.00185	CcSEcCtD
Rescinnamine—Urticaria—Topotecan—lung cancer	0.00026	0.00183	CcSEcCtD
Rescinnamine—Abdominal pain—Topotecan—lung cancer	0.000259	0.00182	CcSEcCtD
Rescinnamine—Erythema—Cisplatin—lung cancer	0.000257	0.00181	CcSEcCtD
Rescinnamine—Abdominal pain—Erlotinib—lung cancer	0.000256	0.0018	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000255	0.0018	CcSEcCtD
Rescinnamine—Paraesthesia—Vinorelbine—lung cancer	0.000252	0.00177	CcSEcCtD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SYP—lung cancer	0.000251	0.0929	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Vinblastine—lung cancer	0.000248	0.00175	CcSEcCtD
Rescinnamine—Cough—Irinotecan—lung cancer	0.000247	0.00174	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Docetaxel—lung cancer	0.000247	0.00174	CcSEcCtD
Rescinnamine—Myocardial infarction—Docetaxel—lung cancer	0.000245	0.00173	CcSEcCtD
Rescinnamine—Hypertonia—Doxorubicin—lung cancer	0.000245	0.00172	CcSEcCtD
Rescinnamine—Hypertension—Irinotecan—lung cancer	0.000244	0.00172	CcSEcCtD
Rescinnamine—Conjunctivitis—Docetaxel—lung cancer	0.000243	0.00171	CcSEcCtD
Rescinnamine—Hypersensitivity—Topotecan—lung cancer	0.000241	0.0017	CcSEcCtD
Rescinnamine—Cough—Gemcitabine—lung cancer	0.000241	0.00169	CcSEcCtD
Rescinnamine—Constipation—Vinorelbine—lung cancer	0.00024	0.00169	CcSEcCtD
Rescinnamine—Pain—Vinorelbine—lung cancer	0.00024	0.00169	CcSEcCtD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—lung cancer	0.000239	0.0885	CbGpPWpGaD
Rescinnamine—Discomfort—Irinotecan—lung cancer	0.000238	0.00168	CcSEcCtD
Rescinnamine—Hypertension—Gemcitabine—lung cancer	0.000238	0.00167	CcSEcCtD
Rescinnamine—Myalgia—Gemcitabine—lung cancer	0.000235	0.00165	CcSEcCtD
Rescinnamine—Discomfort—Gemcitabine—lung cancer	0.000232	0.00163	CcSEcCtD
Rescinnamine—Pruritus—Topotecan—lung cancer	0.000232	0.00163	CcSEcCtD
Rescinnamine—Oedema—Irinotecan—lung cancer	0.000231	0.00163	CcSEcCtD
Rescinnamine—Erythema—Paclitaxel—lung cancer	0.000231	0.00162	CcSEcCtD
Rescinnamine—Dysgeusia—Etoposide—lung cancer	0.000231	0.00162	CcSEcCtD
Rescinnamine—Infection—Irinotecan—lung cancer	0.000229	0.00161	CcSEcCtD
Rescinnamine—Pruritus—Erlotinib—lung cancer	0.000229	0.00161	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vinorelbine—lung cancer	0.000229	0.00161	CcSEcCtD
Rescinnamine—Back pain—Etoposide—lung cancer	0.000228	0.0016	CcSEcCtD
Rescinnamine—Dysgeusia—Paclitaxel—lung cancer	0.000226	0.00159	CcSEcCtD
Rescinnamine—Rhinitis—Docetaxel—lung cancer	0.000225	0.00159	CcSEcCtD
Rescinnamine—Oedema—Gemcitabine—lung cancer	0.000225	0.00158	CcSEcCtD
Rescinnamine—Hypoaesthesia—Docetaxel—lung cancer	0.000224	0.00157	CcSEcCtD
Rescinnamine—Infection—Gemcitabine—lung cancer	0.000224	0.00157	CcSEcCtD
Rescinnamine—Back pain—Paclitaxel—lung cancer	0.000223	0.00157	CcSEcCtD
Rescinnamine—Pharyngitis—Docetaxel—lung cancer	0.000223	0.00157	CcSEcCtD
Rescinnamine—Dizziness—Vinblastine—lung cancer	0.000223	0.00157	CcSEcCtD
Rescinnamine—Urticaria—Vinorelbine—lung cancer	0.000223	0.00157	CcSEcCtD
Rescinnamine—Abdominal pain—Vinorelbine—lung cancer	0.000221	0.00156	CcSEcCtD
Rescinnamine—Myalgia—Cisplatin—lung cancer	0.000219	0.00154	CcSEcCtD
Rescinnamine—Dizziness—Topotecan—lung cancer	0.000217	0.00152	CcSEcCtD
Rescinnamine—Discomfort—Cisplatin—lung cancer	0.000216	0.00152	CcSEcCtD
Rescinnamine—Dizziness—Erlotinib—lung cancer	0.000214	0.00151	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—lung cancer	0.000212	0.00149	CcSEcCtD
Rescinnamine—Headache—Vinblastine—lung cancer	0.000211	0.00149	CcSEcCtD
Rescinnamine—Oedema—Cisplatin—lung cancer	0.00021	0.00148	CcSEcCtD
Rescinnamine—Insomnia—Irinotecan—lung cancer	0.000209	0.00147	CcSEcCtD
Rescinnamine—Infection—Cisplatin—lung cancer	0.000208	0.00147	CcSEcCtD
Rescinnamine—Paraesthesia—Irinotecan—lung cancer	0.000207	0.00146	CcSEcCtD
Rescinnamine—Rash—Topotecan—lung cancer	0.000206	0.00145	CcSEcCtD
Rescinnamine—Hypersensitivity—Vinorelbine—lung cancer	0.000206	0.00145	CcSEcCtD
Rescinnamine—Dermatitis—Topotecan—lung cancer	0.000206	0.00145	CcSEcCtD
Rescinnamine—Cough—Etoposide—lung cancer	0.000205	0.00145	CcSEcCtD
Rescinnamine—Headache—Topotecan—lung cancer	0.000205	0.00144	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000205	0.00144	CcSEcCtD
Rescinnamine—Rash—Erlotinib—lung cancer	0.000204	0.00144	CcSEcCtD
Rescinnamine—Dermatitis—Erlotinib—lung cancer	0.000204	0.00144	CcSEcCtD
Rescinnamine—Insomnia—Gemcitabine—lung cancer	0.000204	0.00143	CcSEcCtD
Rescinnamine—Hypertension—Etoposide—lung cancer	0.000203	0.00143	CcSEcCtD
Rescinnamine—Headache—Erlotinib—lung cancer	0.000203	0.00143	CcSEcCtD
Rescinnamine—Paraesthesia—Gemcitabine—lung cancer	0.000202	0.00142	CcSEcCtD
Rescinnamine—Cough—Paclitaxel—lung cancer	0.000201	0.00142	CcSEcCtD
Rescinnamine—Nausea—Vinblastine—lung cancer	0.0002	0.00141	CcSEcCtD
Rescinnamine—Hypertension—Paclitaxel—lung cancer	0.000199	0.0014	CcSEcCtD
Rescinnamine—Pruritus—Vinorelbine—lung cancer	0.000198	0.00139	CcSEcCtD
Rescinnamine—Discomfort—Etoposide—lung cancer	0.000198	0.00139	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—KIF5B—lung cancer	0.000198	0.0733	CbGpPWpGaD
Rescinnamine—Pain—Irinotecan—lung cancer	0.000198	0.00139	CcSEcCtD
Rescinnamine—Constipation—Irinotecan—lung cancer	0.000198	0.00139	CcSEcCtD
Rescinnamine—Myalgia—Paclitaxel—lung cancer	0.000197	0.00138	CcSEcCtD
Rescinnamine—Erythema—Docetaxel—lung cancer	0.000196	0.00138	CcSEcCtD
Rescinnamine—Nausea—Topotecan—lung cancer	0.000194	0.00137	CcSEcCtD
Rescinnamine—Discomfort—Paclitaxel—lung cancer	0.000194	0.00137	CcSEcCtD
Rescinnamine—Constipation—Gemcitabine—lung cancer	0.000192	0.00135	CcSEcCtD
Rescinnamine—Pain—Gemcitabine—lung cancer	0.000192	0.00135	CcSEcCtD
Rescinnamine—Nausea—Erlotinib—lung cancer	0.000192	0.00135	CcSEcCtD
Rescinnamine—Dysgeusia—Docetaxel—lung cancer	0.000192	0.00135	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000191	0.00134	CcSEcCtD
Rescinnamine—Infection—Etoposide—lung cancer	0.000191	0.00134	CcSEcCtD
Rescinnamine—Back pain—Docetaxel—lung cancer	0.000189	0.00133	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Irinotecan—lung cancer	0.000189	0.00133	CcSEcCtD
Rescinnamine—Oedema—Paclitaxel—lung cancer	0.000188	0.00133	CcSEcCtD
Rescinnamine—Paraesthesia—Cisplatin—lung cancer	0.000188	0.00133	CcSEcCtD
Rescinnamine—Infection—Paclitaxel—lung cancer	0.000187	0.00132	CcSEcCtD
Rescinnamine—Dizziness—Vinorelbine—lung cancer	0.000185	0.0013	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Methotrexate—lung cancer	0.000185	0.0013	CcSEcCtD
Rescinnamine—Abdominal pain—Irinotecan—lung cancer	0.000183	0.00128	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—lung cancer	0.000179	0.00126	CcSEcCtD
Rescinnamine—Pain—Cisplatin—lung cancer	0.000179	0.00126	CcSEcCtD
Rescinnamine—Rash—Vinorelbine—lung cancer	0.000177	0.00124	CcSEcCtD
Rescinnamine—Dermatitis—Vinorelbine—lung cancer	0.000176	0.00124	CcSEcCtD
Rescinnamine—Headache—Vinorelbine—lung cancer	0.000175	0.00123	CcSEcCtD
Rescinnamine—Conjunctivitis—Methotrexate—lung cancer	0.000175	0.00123	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—lung cancer	0.000175	0.00123	CcSEcCtD
Rescinnamine—Paraesthesia—Etoposide—lung cancer	0.000173	0.00121	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000172	0.00121	CcSEcCtD
Rescinnamine—Cough—Docetaxel—lung cancer	0.000171	0.0012	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—lung cancer	0.000171	0.0012	CcSEcCtD
Rescinnamine—Insomnia—Paclitaxel—lung cancer	0.00017	0.0012	CcSEcCtD
Rescinnamine—Hypersensitivity—Irinotecan—lung cancer	0.00017	0.0012	CcSEcCtD
Rescinnamine—Paraesthesia—Paclitaxel—lung cancer	0.000169	0.00119	CcSEcCtD
Rescinnamine—Hypertension—Docetaxel—lung cancer	0.000169	0.00119	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—lung cancer	0.000169	0.00119	CcSEcCtD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—SOX2—lung cancer	0.000167	0.0618	CbGpPWpGaD
Rescinnamine—Myalgia—Docetaxel—lung cancer	0.000167	0.00117	CcSEcCtD
Rescinnamine—Nausea—Vinorelbine—lung cancer	0.000166	0.00117	CcSEcCtD
Rescinnamine—Pain—Etoposide—lung cancer	0.000164	0.00116	CcSEcCtD
Rescinnamine—Constipation—Etoposide—lung cancer	0.000164	0.00116	CcSEcCtD
Rescinnamine—Constipation—Paclitaxel—lung cancer	0.000161	0.00113	CcSEcCtD
Rescinnamine—Pain—Paclitaxel—lung cancer	0.000161	0.00113	CcSEcCtD
Rescinnamine—Pharyngitis—Methotrexate—lung cancer	0.000161	0.00113	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—lung cancer	0.00016	0.00113	CcSEcCtD
Rescinnamine—Oedema—Docetaxel—lung cancer	0.00016	0.00112	CcSEcCtD
Rescinnamine—Pruritus—Gemcitabine—lung cancer	0.000159	0.00112	CcSEcCtD
Rescinnamine—Infection—Docetaxel—lung cancer	0.000159	0.00112	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Etoposide—lung cancer	0.000157	0.00111	CcSEcCtD
Rescinnamine—Hypersensitivity—Cisplatin—lung cancer	0.000155	0.00109	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000154	0.00108	CcSEcCtD
Rescinnamine—Dizziness—Irinotecan—lung cancer	0.000153	0.00107	CcSEcCtD
Rescinnamine—Urticaria—Etoposide—lung cancer	0.000153	0.00107	CcSEcCtD
Rescinnamine—Abdominal pain—Etoposide—lung cancer	0.000152	0.00107	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—lung cancer	0.000152	0.00107	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—lung cancer	0.000152	0.00107	CcSEcCtD
Rescinnamine—Urticaria—Paclitaxel—lung cancer	0.00015	0.00105	CcSEcCtD
Rescinnamine—Abdominal pain—Paclitaxel—lung cancer	0.000149	0.00105	CcSEcCtD
Rescinnamine—Sinusitis—Doxorubicin—lung cancer	0.000147	0.00103	CcSEcCtD
Rescinnamine—Rash—Irinotecan—lung cancer	0.000146	0.00102	CcSEcCtD
Rescinnamine—Dermatitis—Irinotecan—lung cancer	0.000146	0.00102	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000145	0.00102	CcSEcCtD
Rescinnamine—Headache—Irinotecan—lung cancer	0.000145	0.00102	CcSEcCtD
Rescinnamine—Insomnia—Docetaxel—lung cancer	0.000144	0.00102	CcSEcCtD
Rescinnamine—Paraesthesia—Docetaxel—lung cancer	0.000143	0.00101	CcSEcCtD
Rescinnamine—Rash—Gemcitabine—lung cancer	0.000142	0.000998	CcSEcCtD
Rescinnamine—Dermatitis—Gemcitabine—lung cancer	0.000142	0.000997	CcSEcCtD
Rescinnamine—Hypersensitivity—Etoposide—lung cancer	0.000142	0.000996	CcSEcCtD
Rescinnamine—Erythema—Methotrexate—lung cancer	0.000141	0.000992	CcSEcCtD
Rescinnamine—Headache—Gemcitabine—lung cancer	0.000141	0.000992	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—lung cancer	0.000141	0.000989	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—lung cancer	0.00014	0.000982	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—lung cancer	0.000139	0.00098	CcSEcCtD
Rescinnamine—Hypersensitivity—Paclitaxel—lung cancer	0.000139	0.000977	CcSEcCtD
Rescinnamine—Dysgeusia—Methotrexate—lung cancer	0.000138	0.000972	CcSEcCtD
Rescinnamine—Nausea—Irinotecan—lung cancer	0.000137	0.000965	CcSEcCtD
Rescinnamine—Pain—Docetaxel—lung cancer	0.000137	0.000961	CcSEcCtD
Rescinnamine—Constipation—Docetaxel—lung cancer	0.000137	0.000961	CcSEcCtD
Rescinnamine—Back pain—Methotrexate—lung cancer	0.000136	0.00096	CcSEcCtD
Rescinnamine—Pruritus—Etoposide—lung cancer	0.000136	0.000956	CcSEcCtD
Rescinnamine—Nausea—Gemcitabine—lung cancer	0.000134	0.00094	CcSEcCtD
Rescinnamine—Pruritus—Paclitaxel—lung cancer	0.000133	0.000938	CcSEcCtD
Rescinnamine—Rash—Cisplatin—lung cancer	0.000132	0.00093	CcSEcCtD
Rescinnamine—Dermatitis—Cisplatin—lung cancer	0.000132	0.00093	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Docetaxel—lung cancer	0.000131	0.000919	CcSEcCtD
Rescinnamine—Dizziness—Etoposide—lung cancer	0.000127	0.000894	CcSEcCtD
Rescinnamine—Abdominal pain—Docetaxel—lung cancer	0.000126	0.000888	CcSEcCtD
Rescinnamine—Dizziness—Paclitaxel—lung cancer	0.000125	0.000877	CcSEcCtD
Rescinnamine—Nausea—Cisplatin—lung cancer	0.000125	0.000877	CcSEcCtD
Rescinnamine—Cough—Methotrexate—lung cancer	0.000123	0.000866	CcSEcCtD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.000122	0.0453	CbGpPWpGaD
Rescinnamine—Erythema—Doxorubicin—lung cancer	0.000122	0.000859	CcSEcCtD
Rescinnamine—Rash—Etoposide—lung cancer	0.000121	0.000852	CcSEcCtD
Rescinnamine—Dermatitis—Etoposide—lung cancer	0.000121	0.000852	CcSEcCtD
Rescinnamine—Headache—Etoposide—lung cancer	0.00012	0.000847	CcSEcCtD
Rescinnamine—Myalgia—Methotrexate—lung cancer	0.00012	0.000845	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—lung cancer	0.00012	0.000841	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—GRP—lung cancer	0.000119	0.0442	CbGpPWpGaD
Rescinnamine—Rash—Paclitaxel—lung cancer	0.000119	0.000836	CcSEcCtD
Rescinnamine—Dermatitis—Paclitaxel—lung cancer	0.000119	0.000835	CcSEcCtD
Rescinnamine—Discomfort—Methotrexate—lung cancer	0.000119	0.000835	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—lung cancer	0.000118	0.000831	CcSEcCtD
Rescinnamine—Headache—Paclitaxel—lung cancer	0.000118	0.00083	CcSEcCtD
Rescinnamine—Hypersensitivity—Docetaxel—lung cancer	0.000118	0.000828	CcSEcCtD
Rescinnamine—Infection—Methotrexate—lung cancer	0.000114	0.000804	CcSEcCtD
Rescinnamine—Nausea—Etoposide—lung cancer	0.000114	0.000803	CcSEcCtD
Rescinnamine—Pruritus—Docetaxel—lung cancer	0.000113	0.000795	CcSEcCtD
Rescinnamine—Nausea—Paclitaxel—lung cancer	0.000112	0.000787	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—lung cancer	0.000107	0.00075	CcSEcCtD
Rescinnamine—Dizziness—Docetaxel—lung cancer	0.000106	0.000743	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—lung cancer	0.000105	0.000742	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000105	0.000738	CcSEcCtD
Rescinnamine—Insomnia—Methotrexate—lung cancer	0.000104	0.000732	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—lung cancer	0.000104	0.000731	CcSEcCtD
Rescinnamine—Paraesthesia—Methotrexate—lung cancer	0.000103	0.000727	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—lung cancer	0.000103	0.000723	CcSEcCtD
Rescinnamine—Rash—Docetaxel—lung cancer	0.000101	0.000708	CcSEcCtD
Rescinnamine—Dermatitis—Docetaxel—lung cancer	0.000101	0.000708	CcSEcCtD
Rescinnamine—Headache—Docetaxel—lung cancer	0.0001	0.000704	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—lung cancer	9.97e-05	0.000701	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—lung cancer	9.9e-05	0.000697	CcSEcCtD
Rescinnamine—Pain—Methotrexate—lung cancer	9.84e-05	0.000692	CcSEcCtD
Rescinnamine—Nausea—Docetaxel—lung cancer	9.48e-05	0.000667	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Methotrexate—lung cancer	9.41e-05	0.000662	CcSEcCtD
Rescinnamine—Urticaria—Methotrexate—lung cancer	9.14e-05	0.000643	CcSEcCtD
Rescinnamine—Abdominal pain—Methotrexate—lung cancer	9.1e-05	0.00064	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.08e-05	0.000639	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—lung cancer	9.01e-05	0.000634	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—lung cancer	8.95e-05	0.00063	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—lung cancer	8.52e-05	0.0006	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—lung cancer	8.52e-05	0.0006	CcSEcCtD
Rescinnamine—Hypersensitivity—Methotrexate—lung cancer	8.48e-05	0.000597	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—lung cancer	8.15e-05	0.000573	CcSEcCtD
Rescinnamine—Pruritus—Methotrexate—lung cancer	8.14e-05	0.000573	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—lung cancer	7.92e-05	0.000557	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—lung cancer	7.88e-05	0.000554	CcSEcCtD
Rescinnamine—Dizziness—Methotrexate—lung cancer	7.61e-05	0.000535	CcSEcCtD
Rescinnamine—Hypersensitivity—Doxorubicin—lung cancer	7.34e-05	0.000517	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC34A2—lung cancer	7.32e-05	0.0271	CbGpPWpGaD
Rescinnamine—Rash—Methotrexate—lung cancer	7.26e-05	0.000511	CcSEcCtD
Rescinnamine—Dermatitis—Methotrexate—lung cancer	7.25e-05	0.00051	CcSEcCtD
Rescinnamine—Headache—Methotrexate—lung cancer	7.21e-05	0.000507	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—lung cancer	7.05e-05	0.000496	CcSEcCtD
Rescinnamine—Nausea—Methotrexate—lung cancer	6.84e-05	0.000481	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—lung cancer	6.59e-05	0.000464	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIK3—lung cancer	6.37e-05	0.0236	CbGpPWpGaD
Rescinnamine—Rash—Doxorubicin—lung cancer	6.28e-05	0.000442	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—lung cancer	6.28e-05	0.000442	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—lung cancer	6.24e-05	0.000439	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—lung cancer	5.92e-05	0.000416	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A18—lung cancer	5.55e-05	0.0206	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CHRNB4—lung cancer	5.19e-05	0.0192	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIK3—lung cancer	4.88e-05	0.0181	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CHRNA5—lung cancer	4.82e-05	0.0179	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EIF2B4—lung cancer	4.76e-05	0.0176	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—POMC—lung cancer	4.3e-05	0.0159	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—STAT3—lung cancer	4.06e-05	0.0151	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CHRNB4—lung cancer	3.98e-05	0.0147	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CHRNA3—lung cancer	3.93e-05	0.0146	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—KHSRP—lung cancer	3.88e-05	0.0144	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—KIF5B—lung cancer	3.73e-05	0.0138	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	3.72e-05	0.0138	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GNG11—lung cancer	3.72e-05	0.0138	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CHRNA5—lung cancer	3.7e-05	0.0137	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EIF2B5—lung cancer	3.39e-05	0.0126	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—ADCY1—lung cancer	3.34e-05	0.0124	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CHRNA3—lung cancer	3.01e-05	0.0112	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ST3GAL5—lung cancer	2.88e-05	0.0107	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GNG11—lung cancer	2.85e-05	0.0106	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	2.82e-05	0.0105	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—B4GALT5—lung cancer	2.57e-05	0.00952	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ADAMTS1—lung cancer	2.57e-05	0.00952	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—ADCY1—lung cancer	2.56e-05	0.0095	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—GRP—lung cancer	2.25e-05	0.00834	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ATF3—lung cancer	1.96e-05	0.00727	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—LMNA—lung cancer	1.76e-05	0.00653	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—AVP—lung cancer	1.75e-05	0.00647	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCC3—lung cancer	1.69e-05	0.00626	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GNG11—lung cancer	1.53e-05	0.00568	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—BRAF—lung cancer	1.41e-05	0.00524	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ADCY1—lung cancer	1.38e-05	0.00511	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCG2—lung cancer	1.38e-05	0.00511	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TF—lung cancer	1.28e-05	0.00475	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—MDM2—lung cancer	1.18e-05	0.00439	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—RAF1—lung cancer	1.18e-05	0.00438	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—BRAF—lung cancer	1.08e-05	0.00402	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—ALB—lung cancer	1.06e-05	0.00392	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—MMP1—lung cancer	9.76e-06	0.00362	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—MDM2—lung cancer	9.08e-06	0.00336	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—RAF1—lung cancer	9.05e-06	0.00335	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AVP—lung cancer	8.88e-06	0.00329	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—lung cancer	8.6e-06	0.00319	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—POMC—lung cancer	8.11e-06	0.00301	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—MMP2—lung cancer	7.55e-06	0.0028	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—APOA1—lung cancer	6.79e-06	0.00252	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—HRAS—lung cancer	6.5e-06	0.00241	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CXCL8—lung cancer	6.28e-06	0.00233	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—CREBBP—lung cancer	5.75e-06	0.00213	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ALB—lung cancer	5.38e-06	0.00199	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—HRAS—lung cancer	4.98e-06	0.00185	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—RAF1—lung cancer	4.86e-06	0.0018	CbGpPWpGaD
